Search Results

utm_medium=social&utm_source=twitter.com&utm_campaign=buffer #DrGPCR #GPCR #PTH1R #BiasedAgonism #CryoEM #Pharmacology

Tall joined the faculty in the Department of Pharmacology and Physiology at the University of Rochester Tall moved to the University of Michigan in 2016 as an Associate Professor of Pharmacology and is a current

She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology Previously, she held the position of Vice President of Cell Biology & Pharmacology, at Bristol-Myers

Johannes Broichhagen is a group leader at the Leibniz Research Institute for Molecular Pharmacology ( By combining fluorophore design, ligand chemistry, and pharmacology, his work enables precise visualization Ecosystem Johannes Broichhagen LinkedIn Google Scholar Lab Website Leibniz Research Institute for Molecular Pharmacology

Flash News → terrys corner from data to insight Published on July 14, 2025 Category Terry's Corner Pharmacology snapshots can reveal much more—and how predictive frameworks guide modern drug discovery. 🟢 Built for pharmacologists stronger pipelines and those rethinking legacy models. ✳️ https://www.terrykenakin.com #GPCR #DrGPCR #pharmacology

He leads a research group that is focused on understanding the pharmacology and function of a group a

Her work involves the pharmacological and structural characterisation of novel putative antipsychotic

Gaetan Guillemette in the Pharmacology department at the Université de Sherbrooke. The pharmacology of latrophilins brings about a great deal of challenges given that they are highly polymorphic

Steven Foord Steve Foord trained as a Physiologist and Pharmacologist and worked for Glaxo through to He introduced molecular pharmacology to a wide range of the company's GPCR projects and was able to initiate

When the pharmacological properties of these new ligands are deemed exceptional, a lead optimization

Fan is currently an associate professor of Pharmacology and Pathology and Cell Biology at Columbia University

Terry Hébert is a Professor within the Department of Pharmacology & Therapeutics at McGill University

Discover the evolution of GPCR research — from single pipettes to automated platforms shaping precision and insights: https://www.ecosystem.drgpcr.com/gpcr-university-pricing #GPCR #DrGPCR #DrugDiscovery #Pharmacology

Any CRO focused on GPCRs, pharmacology, discovery biology, or antibody discovery—regardless of size or Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution

and adapt quickly with contingency-ready paths " Yamina brings scientific clarity, leadership, and precision execution to complex pharmacological programs. Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution

His lab focuses on developing and innovating technologies to solve broad questions in pharmacology, with

using innovative approaches, including biosensors, cryo-EM, photoswitchable ligands, and nanobodies as pharmacological

She earned her M.Sc. in Zoology and Neurobiology before completing a Ph.D. in Biology and Pharmacology

then Oliver has worked at the University of Geneva, where his research on peptide engineering and GPCR pharmacology

They collaborate deeply with medicinal chemists, pharmacologists, and biotech partners to create workflows GPCR Podcast: model predict discover #DrGPCR #GPCR #CollaborationInScience #ComputationalChemistry #Pharmacology

screening compounds, or designing next-gen molecules, this insight reframes what “success” in computational pharmacology

In April 2009, he joined the Department of Pharmacology and Toxicology at University of Toronto and has

Contest Committee Sponsors GPCR Retreat Program < Back to schedule G Proteins and GPCRs in Cancer: Novel Precision Gutkind is a Distinguished Professor and Chair of the Department of Pharmacology, School of Medicine, dysregulated signaling circuitries and individual genomic and molecular alterations to develop new precision

Maria Waldhoer "I am a pharmacologist with a ~30 years background in academia and industry, working both Trejo joined the faculty in the Department of Pharmacology at the University of North Carolina in 2000 and then moved to UC San Diego School Medicine, Department of Pharmacology in 2008, where she quickly In 2014, she was appointed Vice-Chair of the Department of Pharmacology. The long-term goal of Dr. The precise control of PAR signaling is critical for proper temporal and spatial dynamics of signaling

Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines strategic leaders seeking new drug development models Anyone curious about where AI meets molecular pharmacology Ajay Yekkirala is a molecular pharmacologist, biotech founder, and scientist whose career has been defined rejection letter pivoted him into a PhD program at the University of Iowa, where he studied opioid pharmacology machine learning to explore GPCR structure-function relationships and predict biased signaling with precision

From reluctant intern to scientific leader From local signaling to spatial pharmacology From spark to #GPCR #DrGPCR #SpatialSignaling #Pharmacology #DrugDiscovery #ScientificLeadership #Biotech Previous

Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and

Kari completed her Ph.D. in Pharmacology at Vanderbilt University before continuing her training as a

Join us to learn more about chemosensory GPCRs and how computational pharmacology can help better understand

mainly focused on screening and assay development to bridge the gap between in vitro and in vivo GPCR pharmacology